Clinical Trial Update: Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer [NA]

View source ↗

Summary

The G-MAJOR trial evaluating genomics-guided management in men with newly diagnosed favorable-risk prostate cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING